FindTrial
Sign In

The impact of Long-Acting injectable cabotegravir for HIV Prevention among cisgender men who have sex with men in China: a mathematical modeling Study (LAPS)

The impact of Long-Acting injectable cabotegravir for HIV Prevention among cisgender men who have sex with men in China: a mathematical modeling Study (LAPS)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076045
Enrollment
Unknown
Registered
2023-09-22
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Interventions

MSM group:N/A

Sponsors

Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: (1) Age of at least 18 years. (2) Men self-reported anal intercourse with at least one man in the last 6 months. (3) Have read and understood the study and voluntarily participated in the questionnaire.

Exclusion criteria

Exclusion criteria: (1) Biological sex is not male. (2) Not having sex with men in the last 6 months. (3) Age greater than 64 years.

Design outcomes

Primary

MeasureTime frame
Sexual behavior (in the past one year) ;Awareness of PrEP;PrEP usage;Willingness to use PrEP;—

Secondary

MeasureTime frame
Assessment HIV exposure risk;HIV testing;Condom use;—

Countries

China

Contacts

Public ContactLi Jinghua

Sun Yat-Sen University

lijinghua3@mail.sysu.edu.cn+86 147 1431 3119

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026